Bayer AG said a positive outcome from twin late-stage trials on a promising experimental menopause treatment will help it seek regulatory approval.
Source link
Bayer Menopause Drug Shows Positive Result in Late-Stage Trials
Related Posts
Vista Winds Down Hedge Fund, Citing Dominance of Private Markets
Vista Equity Partners has told investors it’s winding down its hedge fund amid a “structural shift” in markets toward private assets. Source link
T-Mobile Postpones $561 Million Wireless Equipment ABS Offering
T-Mobile US Inc. is postponing its sale of more than $500 million in asset backed securities supported by wireless equipment plans, according to people familiar with the matter. Source link